The neuroimaging space is dynamic, constantly looking for novel approaches to identify and cure complex neurological disorders. Emerging CT (computed tomography) and MRI (magnetic resonance imaging) technologies have helped address the challenges in neuroimaging, such as limited spatiotemporal resolution, cost and accessibility, and patient safety.
• How are emerging technologies like magnetic resonance fingerprinting (MRF), magnetic particle imaging (MPI), positron emission tomography-MR imaging (PET-MRI), silent ZTE (Zero Echo Time) MRI, photon-counting computerized tomography (PCCT), PET-CT, bedside CT, and dual-energy CT transforming this sector?
• What are the potential benefits and outcomes of partnerships between top-tier neuroimaging companies and predictive artificial intelligence startups?
• What is the potential impact of emerging technologies on personalized medicine and precision neurology?
• Which advancements can potentially transform the diagnosis and treatment of neurological disorders?
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled industry intelligence, technology advancements, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.